Double-Blind, Placebo-Controlled Study of the Therapeutic Use of Recombinant Human Erythropoietin for Anemia Associated With Chronic Renal Failure in Predialysis Patients-Reference-Cited by-同舟云学术

Double-Blind, Placebo-Controlled Study of the Therapeutic Use of Recombinant Human Erythropoietin for Anemia Associated With Chronic Renal Failure in Predialysis Patients

Published:1991-07 Issue:1 Volume:18 Page:50-59
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Publisher

Elsevier BV

Subject

Nephrology

Reference26 articles.

1. Anemia of end-stage renal disease (ESRD);Eschbach;Kidney Int,1985

2. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency;McGonigle;Kidney Int,1984

3. The anemia of chronic renal failure in sheep: Response to erythropoietinrich plasma in vivo;Eschbach;J Clin Invest,1984

4. Haemolysis in chronic renal failure;Shaw;Br Med J,1967

5. The therapeutic equivalence of oral and intravenous iron in renal dialysis patients;Strickland;Clin Nephrol,1977

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and cost-effectiveness of darbepoetin alfa once every 4 weeks versus continuous erythropoietin receptor activator once every 4 weeks for anemia correction in patients with chronic kidney disease not on dialysis;Kidney Research and Clinical Practice;2024-05-31

2. The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease;Kidney International;2023-06

3. New Approaches to Diabetic Nephropathy from Bed to Bench;Biomedicines;2022-04-09

4. Anemia in Chronic Kidney Disease;Chronic Kidney Disease, Dialysis, and Transplantation;2019

5. Anemia of Chronic Kidney Disease;Management of Anemia;2017-10-13